First Quadrant’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,833
Closed -$120K 954
2017
Q2
$120K Sell
3,833
-1,767
-32% -$51K ﹤0.01% 761
2017
Q1
$138K Hold
5,600
﹤0.01% 663
2016
Q4
$142K Hold
5,600
﹤0.01% 670
2016
Q3
$111K Hold
5,600
﹤0.01% 713
2016
Q2
$80K Sell
5,600
-5,300
-49% -$81K ﹤0.01% 669
2016
Q1
$169K Buy
+10,900
New +$156K ﹤0.01% 588

Other funds holding LMAT

First Quadrant's LMAT Position: Q3 2017 in Review

First Quadrant sold out of LeMaitre Vascular (LMAT) in Q3 2017, closing a stake of 3,833 shares — an estimated $120K sold.

First Quadrant first reported a position in LMAT in Q1 2016 and held it in 6 quarters. The position peaked at $169K in Q1 2016. 148 funds tracked by Wall St. Rank hold LMAT as of Q3 2017.

  • First Quadrant reported no remaining LeMaitre Vascular position as of Q3 2017 after selling out during the quarter.
  • First Quadrant sold 3,833 LeMaitre Vascular shares in Q3 2017, an estimated $120K.
  • First Quadrant first reported a position in LeMaitre Vascular in Q1 2016 and held it in 6 quarters.
  • First Quadrant's LeMaitre Vascular position peaked at $169K in Q1 2016.
  • 148 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2017.

Based on First Quadrant's 13F filing for Q3 2017, filed 25 Oct 2017.